Dendreon to Pursue Sale or Reorganization in Bankruptcy

Dendreon, a maker of cancer-treatment drugs, said it has reached agreements with certain bondholders on the terms of a financial restructuring of the company.



from WSJ.com: US Business http://ift.tt/1uUYt0q

via IFTTT